Metabolism of l‐bunolol

Authors:
  • JSJoseph M. Szpiech
    Joseph M. Szpiech

Abstract
The metabolism of I‐bunolol, a new f3‐blocking drug, was studied in man after single oral 3‐mg doses of W‐labeled compound. Absorption from the gut was rapid and virtually complete. Peak levels of bunolol and of dihydrobunolol, an active metabolite, were observed at I hr. Excretion of the administered radioactivity was mainly into the urine (78% in 4 days), with only 3% appearing in the feces. Bunolol, bunolol glucuronide, bunolol sulfate, dihydrobunolol, and dihydrobunolol glucuronide were identified and quantified in the plasma. These compounds represented 82% of the radioactivity in plasma at 30 min and 55% at 24 hr. Plasma half‐lives (± S.D.) were estimated to be 6.1 ± 0.3 hr for bunolol, 9.1 ± 1.9 hr for bunolol glucuronide, 17.4 ± 2.5 hr for bunolol sulfate, 7.1 ± 0.5 hr for dihydrobunolol, and 7.7 ± 0.8 hr for dihydrobunolol glucuronide.